Specify a stock or a cryptocurrency in the search bar to get a summary
SIGA Technologies Inc
SIGASIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York. Address: 31 East 62nd Street, New York, NY, United States, 10065
Analytics
WallStreet Target Price
17.53 USDP/E ratio
6.4701Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures SIGA
Dividend Analytics SIGA
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
-274 %Dividend History SIGA
Stock Valuation SIGA
Financials SIGA
Results | 2019 | Dynamics |